NEOMASTIPRA-JR5
Lactating cow mastitis treatment
The best left hook against mastitis
Broad spectrum of action:
It is active against practically all bacterial microorganisms that cause mastitis.
| Antimicrobial |
Staphylo-
coccus
aureus |
Staphylo-
coccus
C.N |
Strepto-
coccus
agalactiae |
Strepto-
coccus
dysgalactiae |
Strepto-
coccus
uberis |
Escherichia
coli |
NEOMASTIPRA
JR5 |
+++ |
+++ |
+++ |
+++ |
+++ |
+++ |
| Enrofloxacin |
+++ |
+++ |
+/- |
+/- |
+/- |
+++ |
Macrolides/
lincosamides |
+++ |
+++ |
+/++ |
+/++ |
+/++ |
- |
| Benzylpenicillin G |
+ |
+ |
+++ |
+++ |
+++ |
- |
| Oxytetracycline |
++ |
++ |
+ |
+ |
+ |
+/++ |
3rd/4th
generation
cephalosporins |
++ |
++ |
++ |
++ |
++ |
+++ |
Activity:: +++ Excellent ++ Good + Low - Nil
Anti-inflammatory effect:
Contains hydrocortisone:
– Anti-inflammatory and analgesic effect.
– Favours the action of the antibiotics.
– Helps rapid recuperation of the affected quarter
– Improves the wellbeing of the cow with mastitis
– Does not represent any risk of miscarriage
NEW FORMAT:
– Sterile syringes: guaranteed quality.
– Flexible cannula and double option cap (short/long cannula): facilitates the application of the product.
– Aseptic: exclusive HIPRA disinfecting towelette. Allows just the tip of the teat to be disinfected. Avoids contamination of the udder when applying NEOMASTIPRA-JR5.
NEOMASTIPRA-JR5. COMPOSITION PER SYRINGE: Benzylpenicillin procaine 100,000 UI; Dihydrostreptomycin (sulphate) 62.4 mg; Neomycin (sulphate) 36 mg; Polymyxin B (sulphate) 50,000 UI;
(Sodium) sulphadimidine 250 mg; Sulphathiazole 250 mg; Hydrocortisone 20 mg. INDICATIONS: Cows: mastitis. ADMINISTRATION ROUTE: Intramammary. WAITING TIME: Milk: 4 days
(8 milkings). SPECIAL PRECAUTIONS: Apply the treatment to the affected quarter after thorough milking and disinfection of the teat, materials and the operator’s hands. Keep in a cool place out
of direct light. By veterinary prescription. FOR VETERINARY USE.
Laboratorios Hipra, S.A. - Avda. la Selva, 135 - 17170 Amer (Girona) Spain - Tel. (34) 972 430 660 - Fax (34) 972 430 661 - E-mail: hipra@hipra.com - www.hipra.com
